Oxygenta Pharma - Quaterly Results

20 May 2022 Evaluate
The sales moved down -36.21% to Rs. 70.76 millions for the March 2022 quarter as compared to Rs. 110.92 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -9.13 millions as compared to Net Profit of Rs. 8.08 millions of corresponding quarter ended March 2021Operating profit Margin for the quarter ended March 2022 slipped to -14.30% as compared to 5.87% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 70.76 110.92 -36.21 605.25 520.27 16.33 605.25 520.27 16.33
Other Income 0.03 0.68 -95.59 0.05 0.91 -94.51 0.05 0.91 -94.51
PBIDT -14.30 5.87 -343.61 14.81 39.34 -62.35 14.81 39.34 -62.35
Interest 1.64 13.25 -87.62 9.25 17.83 -48.12 9.25 17.83 -48.12
PBDT -4.10 14.51 -128.26 11.02 43.40 -74.61 11.02 43.40 -74.61
Depreciation 3.82 4.29 -10.96 15.91 11.96 33.03 15.91 11.96 33.03
PBT -7.92 10.22 -177.50 -4.89 31.44 -115.55 -4.89 31.44 -115.55
TAX 1.21 2.14 -43.46 1.21 2.14 -43.46 1.21 2.14 -43.46
Deferred Tax 1.21 2.14 -43.46 1.21 2.14 -43.46 1.21 2.14 -43.46
PAT -9.13 8.08 -213.00 -6.10 29.30 -120.82 -6.10 29.30 -120.82
Equity 142.01 102.01 39.21 142.01 102.01 39.21 142.01 102.01 39.21
PBIDTM(%) -20.21 5.29 -481.87 2.45 7.56 -67.64 2.45 7.56 -67.64

Oxygenta Pharma Share Price

59.05 -0.50 (-0.84%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×